2024 ICD-10-CM Diagnosis Code D68.8

Other specified coagulation defects

ICD-10-CM Code:
D68.8
ICD-10 Code for:
Other specified coagulation defects
Is Billable?
Yes - Valid for Submission
Chronic Condition Indicator: [1]
Chronic
Code Navigator:

Code Classification

  • Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
    (D50–D89)
    • Coagulation defects, purpura and other hemorrhagic conditions
      (D65-D69)
      • Other coagulation defects
        (D68)

D68.8 is a billable diagnosis code used to specify a medical diagnosis of other specified coagulation defects. The code is valid during the current fiscal year for the submission of HIPAA-covered transactions from October 01, 2023 through September 30, 2024.

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

  • A disintegrin and metalloproteinase with thrombospondin type 1 motif 13 deficiency
  • Abnormal fibrinolysis
  • Acquired coagulation disorder
  • Acquired coagulation factor inhibitor disorder
  • Acquired coagulation factor inhibitor disorder
  • Acquired coagulation factor inhibitor disorder
  • Acquired fibrinogen abnormality
  • Acquired hypofibrinogenemia
  • Acquired hypoplasminogenemia
  • Acquired inhibitor of coagulation
  • Afibrinogenemia
  • Alpha-2-antiplasmin deficiency
  • Alpha-2-antiplasmin deficiency
  • Anticoagulant excess without bleeding
  • Anti-factor II disorder
  • Antiprothrombin disorder
  • Bleeding disorder due to calcium and DAG-regulated guanine exchange factor-1 deficiency
  • Blood coagulation disorder with impaired clot retraction time
  • Blood coagulation disorder with prolonged bleeding time
  • Blood coagulation disorder with prolonged coagulation time
  • Blood coagulation disorder with shortened bleeding time
  • Blood coagulation disorder with shortened coagulation time
  • Blood coagulation disorder, categorized by value of screening test
  • Blood coagulation disorder, categorized by value of screening test
  • Blood coagulation disorder, categorized by value of screening test
  • Blood coagulation disorder, categorized by value of screening test
  • Blood coagulation disorder, categorized by value of screening test
  • Body skin hyperlaxity due to vitamin K dependent coagulation factor deficiency
  • Combined coagulation factor deficiency
  • Congenital alpha-2-antiplasmin deficiency
  • Congenital fibrinogen abnormality
  • Congenital hypofibrinogenemia
  • Decreased fibrinolysis
  • Defect of purinergic receptor p2y G protein-coupled 12
  • Deficiency of naturally occurring coagulation factor inhibitor
  • Disorder involving the fibrinolytic system
  • Drug-induced coagulation inhibitor disorder
  • Drug-induced coagulation inhibitor disorder
  • East Texas bleeding disorder
  • Factor IX inhibitor disorder
  • Factor XI inhibitor disorder
  • Familial multiple factor deficiency syndrome
  • Familial multiple factor deficiency syndrome, type I
  • Familial multiple factor deficiency syndrome, type II
  • Familial multiple factor deficiency syndrome, type III
  • Familial multiple factor deficiency syndrome, type IV
  • Familial multiple factor deficiency syndrome, type V
  • Familial multiple factor deficiency syndrome, type VI
  • Familial thrombomodulin anomalies
  • Fibrinolytic bleeding syndrome
  • Fibrinolytic bleeding syndrome
  • Fibrinolytic bleeding syndrome
  • Fibrinolytic bleeding syndrome
  • Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation
  • Hereditary combined coagulation factor deficiency
  • Hereditary factor I deficiency disease
  • Hereditary hypoplasminogenemia
  • Hypofibrinogenemia
  • Hypoplasminogenemia
  • Hypoplasminogenemia
  • Pseudo von Willebrand disease
  • Thrombomodulin-related bleeding disorder

Clinical Classification

Clinical Information

  • Afibrinogenemia

    a deficiency or absence of fibrinogen in the blood.
  • Fibrinogen

    plasma glycoprotein clotted by thrombin, composed of a dimer of three non-identical pairs of polypeptide chains (alpha, beta, gamma) held together by disulfide bonds. fibrinogen clotting is a sol-gel change involving complex molecular arrangements: whereas fibrinogen is cleaved by thrombin to form polypeptides a and b, the proteolytic action of other enzymes yields different fibrinogen degradation products.
  • Afibrinogenemia

    a blood coagulation disorder characterized by the complete absence of fibrinogen in the blood, resulting in bleeding.

Index to Diseases and Injuries References

The following annotation back-references for this diagnosis code are found in the injuries and diseases index. The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10-CM code(s).

Convert D68.8 to ICD-9-CM

  • ICD-9-CM Code: 286.9 - Coagulat defect NEC/NOS
    Approximate Flag - The approximate mapping means there is not an exact match between the ICD-10 and ICD-9 codes and the mapped code is not a precise representation of the original code.

Patient Education


Bleeding Disorders

Normally, if you get hurt, your body forms a blood clot to stop the bleeding. For blood to clot, your body needs cells called platelets and proteins known as clotting factors. If you have a bleeding disorder, you either do not have enough platelets or clotting factors or they don't work the way they should.

Bleeding disorders can be the result of other diseases, such as severe liver disease or a lack of vitamin K. They can also be inherited. Hemophilia is an inherited bleeding disorder. Bleeding disorders can also be a side effect of medicines such as blood thinners.

Various blood tests can check for a bleeding disorder. You will also have a physical exam and history. Treatments depend on the cause. They may include medicines and transfusions of blood, platelets, or clotting factor.


[Learn More in MedlinePlus]

Code History

  • FY 2024 - No Change, effective from 10/1/2023 through 9/30/2024
  • FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
  • FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016. This was the first year ICD-10-CM was implemented into the HIPAA code set.

Footnotes

[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:

  • The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
  • The condition places limitations on self-care, independent living, and social interactions.